Cell damage, aging and transformation: A multilevel analysis of carcinogenesis

Anticancer Research

Volumn 19, Issue 6 A, 1999, Pages 4877-4886

  Rubin, Harry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Carcinogenesis; Cell damage; Transformation

Indexed keywords

CARCINOGEN; MUTAGENIC AGENT;

ATROPHY; BLADDER CARCINOMA; CANCER; CANCER GROWTH; CARCINOGENESIS; CELL AGING; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL DENSITY; CELL DIVISION; CELL GROWTH; CELL TRANSFORMATION; CHROMOSOME DELETION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SOMATIC CELL GENETICS; STOMACH CANCER;

ANIMALS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC;

EID: 0033382990     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Temin H and Rubin H: Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 6: 669-688, 1958.
2. Rubin H and Temin H: A radiological study of cell-virus interaction in the Rous sarcoma. Virology 7: 75-91, 1959.
3. Hayflick L and Moorhead P: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
4. Todaro GJ and Green H: Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17: 299-313, 1963.
5. Aaronson SA and Todaro GJ: Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science 162: 1024-1026, 1968.
6. Jainchill JL, Aaronson SA and Todaro GJ: Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol 4: 549-553, 1969.
7. Shin C, Padhy LC, Murray M and Weinberg RA: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-264, 1981.
8. Perucho M, Golfarb M, Shimizu K, Lama C, Fogh J and Wigler M: Human-tumor-derived cell lines contain common and different transforming genes. Cell 27: 467-476, 1981.
9. Krontiris TG and Cooper GM: Transforming activity of human tumor DNAs. Proc Natl Acad Sci USA 78: 1181-1184, 1981.
10. Weinberg RA: Oncogenes and the molecular biology of cancer. J Cell Biol 97: 1661-1662, 1983.
11. Chakraborty AK, Cichutek K and Duesberg P: Transforming function of proto-ras genes depends on heterologous promoters and is enhanced by specific point mutations. Proc Natl Acad Sci USA 88: 2217-2221, 1991.
12. Hua V, Wang WK and Duesberg P: Dominant transformation by mutated ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proc Natl Acad Sci USA 94: 9614-9619, 1997.
13. Cichutek K and Duesberg PH: Recombinant BALB and Harvey sarcoma viruses with normal proto-ras-coding regions transform embryo cells in culture and cause tumors in mice. J Virol 63: 1377-1383, 1989.
14. Rubin H and Xu K: Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc Natl Acad Sci USA 86: 1860-1864, 1989.
15. Rubin H: Experimental control of neoplastic progression in cell populations: Foulds' rules revisited. Proc Natl Acad Sci USA 91: 6619-6623, 1994.
16. Rubin H: Incipient and overt stages of neoplastic transformation. Proc Natl Acad Sci USA 91: 12076-12080, 1994.
17. Rubin H: 'Spontaneous' transformation as aberrant epigenesis. Differentiation 53: 123-137, 1993.
18. Rubin H, Yao A and Chow M: Heritable, population-wide damage to cells as the driving force of neoplastic transformation. Proc Natl Acad Sci USA 92: 4843-4847, 1995.
19. Tomei LD, Shapiro J.P and Cope FO: Apoptosis in C3H/10T1/2 mouse embryonic cells: Evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 90: 853-857, 1993.
20. Brown DG, Sun X-M and Cohen GM: Dexamethasone-induced apoptosis involves cleavage to large fragments prior to internucleosomal fragmentation. J Biol Chem 268: 3037-3039, 1993.
21. +/- mouse lymphoma mutagen system. Mutation Res 59: 61-108, 1979.
22. Hozier J, Sawyer J, Clive D and Moore M: Chromosome II aberrations in small colony L5178Y TK-/-mutants early in their clonal history. Mutation Res 147: 237-242, 1985.
23. Evans HH: The prevalence of multilocus lesions in radiation-induced mutants. Radiation Res 137: 131-144, 1994.
24. Chow M and Rubin H: Irreversibility of cellular aging and neoplastic transformation: A clonal analysis. Proc Natl Acad Sci USA 93: 9793-9798, 1996.
25. Rodriguez E, Sreekanitaiah C and Chaganti RSK: Genetic changes in epithelial solid neoplasia. Cancer Res 54: 3398-3406, 1994.
26. Cairns J: The origin of human cancers. Nature 289: 353-357, 1981.
27. Mitelman F, Mertens F and Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genetics 15: 417-474, 1997.
28. Arber W, Iida S, Jutte H, Caspers P, Meyer J and Hanni C: Rearrangements of genetic material in Escherichis coli as observed on the bacteriophage P1 plasmid. Cold Spring Harbor Symposia-Quant Biol 43: 1197-1203, 1978.
29. Longerich S, Galloway AM, Harris RS, Wong C and Rosenberg SM: Adaptive mutation sequences reproduced by mismatch repair deficiency. Proc Natl Acad Sci USA 92: 12017-12020, 1995.
30. Brand KG: Cancer associated with asbestosis, schistosomiasis, foreign bodies, and scars. In: F. F. Backer (ed.), Cancer: a Comprehensive Treatise, Vol. 4, pp. 661-692. New York: Plenum Press, 1982.
31. Brand K. G: Solid state carcinogenesis. In: Banbury Report: Non-Genotoxic Mechanisms in Carcinogenesis. Cold Spring Harbor Laboratory 205-213, 1984.
32. Noble RL: Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res 37: 82-94, 1977.
33. Richards B, Zhang H, Phear G and Meuth M: Conditional mutator phenotypes in hMSH2-deficient tumor cell lines. Science 277: 1523-1527, 1997.
34. Goncharova El, Nádas A and Rossman TG: Serum deprivation, but not inhibition of growth per se, induces a hypermutable state in Chinese hamster G12 cells. Cancer Res 56: 752-756, 1996.
35. Yao A, Rubin AL and Rubin H: Progressive state selection of cells in low serum promotes high density growth and neoplastic transformation in NIH 3T3 cells. Cancer Res 50: 5171-5176, 1990.
36. Rowley JD: Mapping of human chromosomal regions related to neoplasia: Evidence from chromosome 1 and 17. Proc Natl Acad Sci USA 74: 5729-5733, 1977.
37. Azzarone B and Macieira-Coelho A: Further characterization of skin fibroblasts from cancer patients. J Cell Sci 87: 155-162, 1987.
38. Azzarone B, Chaponnier C, Krief P, Marcel M, Suarez H and Macieira-Coelho A: Human fibroblasts from cancer patients: lifespan and transformed phenotype in vitro and role of mesenchyme in vivo. Mutation Res 199: 313-325, 1988.
39. Danes SB: Heritable colonic cancer syndrome: Induction of anchorage-independence in dermal cultures derived from patients with adenomatosis of the colon and rectum. Oncology 37: 386-389, 1980.
40. Smith HS, Owens RB, Hiller AJ, Nelson-Rees WA and Johnston JO: The biology of human cells in tissue culture. 1. Characterization of cells derived from osteogenic sarcomas. Intl J Cancer 17: 219-234, 1976.
41. Kopelovich L: The transformed (initiated) human cell phenotype: study of cultured skin fibroblasts from individuals predisposed to cancer. Mutation Res 199: 369-385, 1988.
42. Chen S, Kazim D, Kraveka J and Pollack RE: Skin fibroblasts from individuals hemizygous for the familial adenopolyposis susceptibility gene show delayed crisis in vitro. Proc Natl Acad Sci USA 86: 2008-2012, 1989.
43. Tainsky MA, Zamanigan F, Yim SO, Pathak S, Grovanalla BC and Strong LC: Fibroblasts derived from patients with Li-Fraumeni cancer syndrome spontaneously transform in vitro. Proc Amer Assn Cancer Res 30: 315, 1989.
44. Lynch HT, Alban WA, Danes BS, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA and Tindall SA: Genetic predisposition to cancer. Cancer 53: 612-622, 1984.
45. Rubin H: The suppression of morphological alterations in cells infected with Rous sarcoma virus. Virology 12: 14-31, 1960.
46. Rubin H: Cellular epigenetics: Control of the size, shape and spatial distribution of transformed foci by interactions between the transformed and non-transformed cells. Proc Natl Acad Sci USA 91: 1039-1043, 1994.
47. Waddington CH: Cancer and the theory of organizers. Nature 135: 606-608, 1935.
48. Needham J: New advances in chemistry and biology of organized growth. Proc Roy Soc B29: 1577-1626, 1936.
49. Fujii H, Cunha GR and Norman JT: The induction of adenocarcinomatous differentiation in neoplastic bladder epithelium by an embryonic prostatic inductor. J Urol 128: 858-861, 1982.
50. Rubin H: Cancer as a dynamic developmental disorder. Cancer Res 45: 2935-2942, 1985.
51. Foulds L: Tumor progression: a review. Cancer Res 14: 327-339, 1954.
52. Foulds L: Neoplastic Development, Vol. I. New York: Academic Press, 1969.
53. Slaughter DP, Southwick HW and Sinejkal W: "Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila.) 6: 963-968, 1953.
54. Rao JY, Hemstreet III GP, Hurst RE, Bonner RB, Jones PL, Min KW and Fradet Y: Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci USA 90: 8287-8291, 1993.
55. Deng G, Lu Y, Zlotnikov G, Thor AD and Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059, 1996.
56. Reid BJ, Haggitt RC, Rubin CE and Rabinovitch PS: Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93: 1-11, 1987.
57. Boland RC: Transitional mucosa of the colon and tumor growth factors. Medical Hypotheses 22: 237-243, 1987.
58. El-Deiry Nelkin BD, Celano P, Yen R-WC, Falco JP, Hamilton SR and Baylin SB: High expression of the DNA methyl transferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 88: 3470-3474, 1991.
59. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W and Sidransky, D: Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56: 2488-2492, 1996.
60. Fialkow PJ: Clonal origin of human tumors. Biochimica et Biophysica Acta 458: 283-321, 1976.
61. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC and Vogelstein B: Clonal origin of bladder cancer. N Engl J Med 326: 737-740, 1992.
62. Bedi GC, Westra WH, Gabrielson E, Koch W and Sidransky D: Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56: 2484-2487, 1996.
63. Mehta PP, Bertram JS and Loewenstein WR: Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44: 187-196, 1986.
64. Cha RS, Guerra L, Thilly WG and Zarbl, H: Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats. Carcinogenesis 17: 2519-2524, 1996.
65. Jones HB: Demographic consideration of the cancer problem. Trans. NY Acad Sci 18: 298-333, 1956.
66. Dix D and Cohen P: On the role of aging in cancer incidence. J.Theor Biol 83: 163-173, 1980.
67. Riggs JE: Longitudinal Gompertzian analysis of prostate cancer mortality in the US, 1962-1987; A method of demonstrating relative environmental, genetic and competitive influences upon mortality. Mech Ageing Dev 60: 243-253, 1991.
68. Clive JM and Spencer RP: Analysis of mortality from carcinoma of the prostate. Mech Ageing Dev 83: 31-41, 1995.
69. Rubin H: Cell aging in vivo and in vitro. Mech Ageing Dev 98: 1-35, 1997.
70. Stoker M: Regulation of growth and orientation in hamster cells transformed by polyomavirus. Virology 24: 165-174, 1964.
71. Stoker M, Shearer M and O'Neill C: Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1: 297-310, 1966.
72. Weiss RA: The influence of normal cells on the proliferation of tumor cells in culture. Exp Cell Res 63: 1-18, 1970.
73. McCullough KD, Coleman WR, Smith GJ and Grisham JW: Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res 57: 1807-1813, 1997.
74. Wareham KA, Lyon MF, Glenister PH and Williams ED: Age related reactivation of an X-linked gene. Nature 327: 725-727, 1987.
75. Elsasser WM: Reflections on a Theory of Organisms. Frelighsburg, Quebec, Canada, To be reissued by Johns Hopkins Univ. Press, Baltimore, MD, August 21, 1998: Editions Orbis Publishing, 1987.
76. Weiss P: The Science of Life. Futura Pub. Co, Mt. Kisco, New York: 1973.
77. Sperry RW: A modified concept of consciousness. Psychol Rev 76: 532-536, 1969.
78. Ramsey MJ, Moore DH, Briner JF, Lee DA, Olsen LA, Senft JR and Tucker JD: The effects of age and lifespan factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutation Res 338: 95-106, 1996.
79. Vijg J, Martijn ET, Martus H-J and Boerrigter M: Transgenic mouse models for studying mutations in vivo: applications in aging research. Mech. Ageing and Dev 99: 257-271, 1997.
80. Farber E: The multistep nature of cancer development. Cancer Res 44: 4217-4223, 1984.
81. Varmus HE: The molecular genetics of cellular oncogenes. Annu Rev Genet 18: 553-612, 1984.
82. Teich NM: Oncogenes and cancer. In: LM Franks and NM Teich (ed.), Introduction to the Cellular and Molecular Biology of Cancer, pp. 169-201. Oxford, New York, Tokyo: Oxford University Press, 1997.
83. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
84. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 2488-2492, 1994.
85. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith H, Pinkel D, Gray JW and Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. USA 91: 2156-2160, 1994.
86. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB and Jensen RH: Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56: 3091-3102, 1996.
87. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichsteiner S and Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
88. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
89. Frenck RW, Blackburn EH and Shannon KM: The rate of telomerase sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 95: 5607-5610 1998.
90. Lundblad V and Wright WE: Telomeres and telomerase: A simple picture becomes complex. Cell 87: 369-375, 1996.
91. Kyo S, Takakura M, Kohama T and Masaki I: Telomerase activity in human endometrium. Cancer Res 57: 610-614, 1997.
92. Buchkovich KJ and Greider CW: Telomerase regulation during entry into the cell cycle in normal human T cells. Molec Biol of the Cell 7: 1443-1454, 1996.
93. Belair CD, Yeager TR, Lopez PM and Reznikoff CA: Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677-13682, 1997.
94. Blasco MA, Rizen M, Hanahan D and Greider CW: Regulation of mouse telomerase in cell immortalization and cancer. Proc AACR for Cancer Res 37: 661, 1996.
95. Blasco MA, Lee H, Hande MP, Samper E Lansdorf PM, DePinho RA and Greider CW: Telomere shortening and tumor formation by mouse fibroblasts lacking telomerase RNA. Cell 91: 25-34, 1997.
96. Morgan TL, Yang D, Fry DC, Hurlin PJ, Kohler SK, Maher VM and McCormick JJ: Characteristics of an infinite life span diploid human fibroblast cell strain and a near diploid strain arising from a clone of cells expressing a transfected v-myc oncogene. Exp Cell Res 197: 125-136, 1991.
97. Tsujimoto Y, Gorham J, Cassman J, Jaffe E and Croce CM: The t (14; 18) chromosome translations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393, 1985.
98. Sentman CL, Shutter JR, Hockenberry D, Kanagawa O and Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888, 1991.
99. Ruhin H, Chow M and Yao A: Cellular aging, destabilization and cancer. Proc Natl Acad Sci USA 93: 1825-1830, 1996.
100. Chow M and Rubin H: Evidence for cellular aging in long term confluent cultures: heritable impairment of proliferation, accumulation of age pigments and their loss in neoplastic transformation. Mech Ageing Dev 89: 165-184, 1996.
101. Brandes D: The fine structure and histochemistry of prostatic glands in relation to sex hormones. Int'l Rev Cytol 20: 207-276, 1966.
102. Franks LM: Atrophy and hyperplasia in the prostate proper. J Path and Bact 68: 617-621, 1954.
103. Correa P: Human gastric carcinogenesis: A multistep and multi-factorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735-6740, 1992.
104. Farber E: Programmed cell death: Necrosis vs. apoptosis. Modern Pathology 1: 605-609, 1994.
105. Chow M and Robin H: The cellular ecology of progressive neoplastic transformation. Proc Natl Acad Sci USA 96: 2093-2098, 1999.